Drug Shortage Report for DOCETAXEL INJECTION
Report ID | 215330 |
Drug Identification Number | 02439336 |
Brand name | DOCETAXEL INJECTION |
Common or Proper name | DOCETAXEL |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | DOCETAXEL |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1ML |
ATC code | L01CD |
ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-01-08 |
Estimated end date | 2024-02-09 |
Actual end date | 2024-01-05 |
Shortage status | Avoided shortage |
Updated date | 2024-02-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2024-02-05 | French | Compare |
v8 | 2024-02-05 | English | Compare |
v7 | 2024-01-30 | French | Compare |
v6 | 2024-01-30 | English | Compare |
v5 | 2024-01-09 | English | Compare |
v4 | 2024-01-08 | French | Compare |
v3 | 2024-01-08 | English | Compare |
v2 | 2024-01-08 | English | Compare |
v1 | 2024-01-08 | English | Compare |
Showing 1 to 9 of 9